Picture of MCH AG logo

MCHN MCH AG News Story

0.000.00%
ch flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapSuper Stock

Swiss stocks - Factors to watch on May 7

ZURICH/BERLIN, May 7 (Reuters) - The Swiss blue-chip SMI
 .SSMI  was seen opening little changed at 9,575 points on
Thursday, according to premarket indications by bank Julius Baer
 JBPRE01 .
    Here are some of the main factors that may affect Swiss
stocks:
    
    CREDIT SUISSE  CSGN.S 
    The Swiss bank said the COVID-19 impact on its ROTE goal for
2020 cannot be predicted at this time.  CSGN.S 
    
    ROCHE  ROG.S  
    Chief Executive Severin Schwan said it is too early to say
if the coronavirus crisis will make it easier to acquire
companies, but he would not rule it out, according to an
interview in Neue Zuercher Zeitung.  ROG.S 
    
    NOVARTIS  NOVN.S 
    The company priced its treatment for a hard-to-treat form of
lung cancer at the U.S. wholesale acquisition cost of $17,950
for a 28-day supply, following the drug's approval by
regulators.  urn:newsml:reuters.com:*:nL4N2CO3KT
    
    MCH GROUP  MCHN.S 
    The trade fair organiser canceled Baselworld 2021, after
scrubbing the 2020 event due to the coronavirus. "Together with
the exhibitors and visitors, we are working intensively on
clarifying and discussing the requirements and options for new
platforms," it said.  MCHN.s 
    
    COMPANY STATEMENTS
    * Schaffner  SAHN.S  reported half-year EPS of 0.88 Swiss
francs. It added that the overall impact of Covid-19 on sales
and results cannot be assessed accurately at this
time. urn:newsml:reuters.com:*:nFWN2CO1I0
    * Adecco Group  ADEN.S  said it has raised 225 million Swiss
francs in a bond issue, due in November 2025.  ADEN.S 
    * ABB  ABBN.S  said it has won $180 million in orders from
rail manufacturer Stadler to supply equipment for more than 160
trains in Europe and North America.  ABBN.S 
    * Roche  ROG.S  outlined data releases for the ASCO20
Virtual Scientific Program for new drugs, including initial
information on its novel anti-TIGIT cancer immunotherapy, in
combination with Tecentriq.  ROG.S 
    
    ANALYSTS' VIEWS
    * ADECCO  ADEN.S  - Goldman Sachs raises to neutral from
sell
    * LANDIS + GYR  LANDI.S  - JP Morgan cuts target price to 64
Swiss francs from 72 Swiss francs
    
    EX-DIVIDEND
    CREDIT SUISSE  CSGN.S  - 0.14 chf/shr dividend
    
    ECONOMY
    * Swiss jobless rate up at 3.3% in April  urn:newsml:reuters.com:*:nS8N2CH014
    * Swiss April forex reserves data due at 0700 GMT 
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on MCH AG

See all news